ClassID:

21647

A61K2300/00 - page 5 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#1201
20190030050
2019-01-31

NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME

#1202
20190030034
2019-01-31

Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors

#1203
20190030026
2019-01-31

Multi-drug therapies for tuberculosis treatment

#1204
20190030015
2019-01-31

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#1205
20190030011
2019-01-31

Use of histone deacetylase inhibitors for enhancing immunotherapies

#1206
20190030008
2019-01-31

CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES

#1207
20190030005
2019-01-31

THERAPEUTIC AGENT FOR DYSLIPIDEMIA

#1208
20190030001
2019-01-31

Glucocorticoid receptor modulators to treat pancreatic cancer

#1209
20190029999
2019-01-31

Compositions comprising melatonin

#1210
20190029995
2019-01-31

Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption

#1211
20190029994
2019-01-31

Biophotonic compositions for the treatment of otitis externa

#1212
20190029993
2019-01-31

QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES

#1213
20190029985
2019-01-31

DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM

#1214
20190029983
2019-01-31

Method, composition and package for bowel cleansing

#1215
20190029982
2019-01-31

Combination composition

#1216
20190029980
2019-01-31

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

#1217
20190029964
2019-01-31

Sumatriptan promethazine pharmaceutical compositions

#1218
20190029963
2019-01-31

High surface-area lyophilized compositions comprising arsenic for oral administration in patients

#1219
20190029938
2019-01-31

Topical testosterone (T) for promoting hair growth—containing formulations

#1220
20190029313
2019-01-31

TOBACCO COMPOSITIONS

#1221
20190024084
2019-01-24

Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

#1222
20190024048
2019-01-24

Therapeutic apoptotic cell preparations, method for producing same and uses thereof

#1223
20190023804
2019-01-24

Immunologic treatment of cancer

#1224
20190023743
2019-01-24

METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION

#1225
20190023716
2019-01-24

FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#1226
20190023694
2019-01-24

Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria

#1227
20190022246
2019-01-24

Nanoparticle-cell construct with platinum anti-cancer agent

#1228
20190022235
2019-01-24

Osteotropic nanoparticles for prevention or treatment of bone metastases

#1229
20190022232
2019-01-24

Stabilized vancomycin formulations

#1230
20190022226
2019-01-24

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

#1231
20190022204
2019-01-24

Cancer vaccines and methods of delivery

#1232
20190022198
2019-01-24

Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia

#1233
20190022197
2019-01-24

MODULATION OF YEAST-BASED IMMUNOTHERAPY PRODUCTS AND RESPONSES

#1234
20190022191
2019-01-24

Mutant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) compositions and methods of treating cancer

#1235
20190022187
2019-01-24

IL-15-based molecules and methods of use thereof

#1236
20190022181
2019-01-24

Mutant peptides and methods of treating subjects using the same

#1237
20190022179
2019-01-24

Isolated polypeptide and compositions comprising same

#1238
20190022176
2019-01-24

USE OF MK2 INHIBITOR PEPTIDE-CONTAINING COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WITH SAME

#1239
20190022173
2019-01-24

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#1240
20190022169
2019-01-24

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES, CONDITIONS, OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION

#1241
20190022167
2019-01-24

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

#1242
20190022166
2019-01-24

ORAL ANTI-INFLAMMATORY PEPTIDES TO TREAT EPILEPSY, SEIZURES AND CNS DISORDERS

#1243
20190022165
2019-01-24

METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PULMONARY ARTERIAL HYPERTENSION

#1244
20190022139
2019-01-24

Fast acting inhibitor of gastric acid secretion

#1245
20190022135
2019-01-24

TREATMENT FOR CHITIN-CONTAINING MICROORGANISMS

#1246
20190022123
2019-01-24

RNAi therapy for hepatitis B virus infection

#1247
20190022122
2019-01-24

Carboline derivatives or phosphorous derivatives for the treatment of muscular myopathies and traumatic injuries to muscles

#1248
20190022110
2019-01-24

AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE

#1249
20190022109
2019-01-24

Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen

#1250
20190022094
2019-01-24

Compositions and methods for inhibiting Dkk-1

#1251
20190022093
2019-01-24

Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer

#1252
20190022083
2019-01-24

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

#1253
20190022080
2019-01-24

Crystalline forms of a prolyl hydroxylase inhibitor

#1254
20190022077
2019-01-24

Compositions and methods for prophylaxis and treatment of addictions

#1255
20190022071
2019-01-24

METHODS OF TREATING PULMONARY DISEASES AND DISORDERS

#1256
20190022070
2019-01-24

Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders

#1257
20190022063
2019-01-24

Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme

#1258
20190022062
2019-01-24

Uses of indolinone compounds

#1259
20190022056
2019-01-24

Polyphenol-reactive oxygen species compositions and methods

#1260
20190022043
2019-01-24

METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE

#1261
20190022042
2019-01-24

Extended, delayed and immediate release formulation method of manufacturing and use thereof

#1262
20190022036
2019-01-24

CAPSAICIN SEQUENTIAL DOSING METHOD FOR TREATMENT OF MORTON'S NEUROMA PAIN

#1263
20190022033
2019-01-24

TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

#1264
20190022029
2019-01-24

Formulation and process for modulating wound healing

#1265
20190022020
2019-01-24

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

#1266
20190022016
2019-01-24

COMPOSITIONS FOR SUSTAINED RELEASE OF ANTI-GLAUCOMA AGENTS TO CONTROL INTRAOCULAR PRESSURE

#1267
20190022000
2019-01-24

ANTI-INFECTION AUGMENTATION FOAMABLE COMPOSITIONS AND KIT AND USES THEREOF

#1268
20190021366
2019-01-24

Saponin and bacterial compositions and methods

#1269
20190021330
2019-01-24

Compositions comprising peroxyacid and methods for producing and using the same

#1270
20190017024
2019-01-17

Methods for inducing migration by dendritic cells and an immune response

#1271
20190016819
2019-01-17

Anti-CD20 combinations for treating tumors

#1272
20190016814
2019-01-17

Activatable anti-PDL1 antibodies, and methods of use thereof

#1273
20190016813
2019-01-17

Anti-CD43 antibody and use thereof for cancer treatment

#1274
20190016808
2019-01-17

Anti-EGFR combinations for treating tumors

#1275
20190016744
2019-01-17

Phenylpropanoid compound and preparation method and use thereof

#1276
20190016726
2019-01-17

TDO2 Inhibitors

#1277
20190016713
2019-01-17

Heterocyclic inhibitors of ATR kinase

#1278
20190016701
2019-01-17

TRPA1 modulators

#1279
20190016686
2019-01-17

SALTS OF COMPOUNDS HAVING A BENZIMIDAZOLIC STRUCTURE, USES AND PROCESS FOR THE PREPARATION THEREOF

#1280
20190016682
2019-01-17

Azepane derivatives and methods of treating hepatitis B infections

#1281
20190015523
2019-01-17

ELP fusion proteins for controlled and sustained release

#1282
20190015511
2019-01-17

Pre-mixed, ready-to-use pharmaceutical compositions

#1283
20190015510
2019-01-17

Methods for manufacturing phthalocyanine dye conjugates and stable conjugates

#1284
20190015506
2019-01-17

Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor

#1285
20190015485
2019-01-17

Method of treating diabetic nephropathy comprising administering plasminogen

#1286
20190015480
2019-01-17

Methods and compositions for treating neurodegenerative and neuroinflammatory conditions

#1287
20190015448
2019-01-17

Treatment and Prevention of Bone and Joint Disorders

#1288
20190015437
2019-01-17

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1289
20190015434
2019-01-17

DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE

#1290
20190015433
2019-01-17

Lipid compositions with high DHA content

#1291
20190015432
2019-01-17

Lipid disulfide prodrugs and uses related thereto

#1292
20190015427
2019-01-17

METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING

#1293
20190015423
2019-01-17

REGULATION OF GENE EXPRESSION BY MODULATING PRIMARY CILIA LENGTH

#1294
20190015419
2019-01-17

Deuterated analogs of etifoxine, their derivatives and uses thereof

#1295
20190015417
2019-01-17

Therapeutic agent for FGFR inhibitor-resistant cancer

#1296
20190015414
2019-01-17

Formulations of 5-fluorocytosine and uses thereof

#1297
20190015404
2019-01-17

Kinase inhibitors for treatment of disease

#1298
20190015403
2019-01-17

Niacin formulation

#1299
20190015400
2019-01-17

Antifungal Compositions

#1300
20190015399
2019-01-17

Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions

#1301
20190015393
2019-01-17

THE USE OF A TEMPORARY INHIBITOR OF P53 FOR PREVENTING OR REDUCING CANCER RELAPSE

#1302
20190015392
2019-01-17

Treatment of Gout and Hyperuricemia

#1303
20190015388
2019-01-17

Compositions comprising corneoscleral tissue cross-linking agents

#1304
20190015384
2019-01-17

Treatment and prevention of joint disorders

#1305
20190015381
2019-01-17

Cannabinoid Formulation and Products

#1306
20190015380
2019-01-17

CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states

#1307
20190015377
2019-01-17

Compositions for Use in Treating Pulmonary Arterial Hypertension

#1308
20190015365
2019-01-17

Compositions and methods for treating autism

#1309
20190015364
2019-01-17

Compositions and methods for treating autism

#1310
20190015361
2019-01-17

POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRTESSION MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER CONDITIONS

#1311
20190015360
2019-01-17

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation

#1312
20190014807
2019-01-17

Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof

#1313
20190010445
2019-01-10

Bioprotection using lactobacillus paracasei strains

#1314
20190010246
2019-01-10

Triple combination antibody therapies

#1315
20190010201
2019-01-10

Polypeptide for inhibition of tumor

#1316
20190010139
2019-01-10

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1317
20190010132
2019-01-10

Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

#1318
20190010128
2019-01-10

1-ARYL-3-AMINOALKOXY PYRAZOLES AS SIGMA LIGANDS ENHANCING ANALGESIC EFFECT OF OPIOIDS AND ATTENUATING THE DEPENDENCY THEREOF

#1319
20190008968
2019-01-10

Progesterone formulations

#1320
20190008960
2019-01-10

IL-12 P40 monomer, monoclonal antibody against P40 homodimer and the combination of the two for autoimmune disease treatment

#1321
20190008959
2019-01-10

Localized immunosuppression of allografts for peripheral nerve repair

#1322
20190008958
2019-01-10

Localized immunosuppression of allografts for peripheral nerve repair

#1323
20190008928
2019-01-10

Methods for inhibiting tumor growth

#1324
20190008922
2019-01-10

Use of annexin V to reduce the spread of intracellular pathogens

#1325
20190008906
2019-01-10

COMPOSITIONS FOR MANAGEMENT OF WOUNDS, SKIN DISEASES, DEHYDRATION, CHRONIC DISEASES, AND RESPIRATORY DISEASES

#1326
20190008899
2019-01-10

Tumor infiltrating lymphocytes and methods of therapy

#1327
20190008896
2019-01-10

Methods and Systems for the Prevention, Treatment and Management of Disease and Effects of Aging Via Cell-to-Cell Restoration Therapy Using Subcellular Transactions

#1328
20190008885
2019-01-10

MiRNA biomarkers for cartilage degeneration

#1329
20190008883
2019-01-10

Compositions comprising nicotinamide riboside and a urolithin

#1330
20190008879
2019-01-10

TREATMENT FOR CANCER BY A COMBINATION OF AN INOSITOL PHOSPHORIC DERIVATIVE AND MAGNESIUM CHLORIDE

#1331
20190008878
2019-01-10

COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY

#1332
20190008870
2019-01-10

COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER

#1333
20190008863
2019-01-10

Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

#1334
20190008859
2019-01-10

Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor

#1335
20190008857
2019-01-10

Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists

#1336
20190008855
2019-01-10

CANCER TREATMENT METHOD

#1337
20190008853
2019-01-10

Method for treating a protozoal infection

#1338
20190008852
2019-01-10

Antiproliferative compounds and methods of use thereof

#1339
20190008851
2019-01-10

Compositions and kits useful for treatment of respiratory illness

#1340
20190008844
2019-01-10

Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug

#1341
20190008840
2019-01-10

Bis-amines, compositions, and uses related to CXCR4 inhibition

#1342
20190008839
2019-01-10

Hyperphenylalaninemia and treatments thereof

#1343
20190008832
2019-01-10

COMPOSITIONS FOR THE TREATMENT OF PRESBYOPIA

#1344
20190008819
2019-01-10

Methods and Compositions Using Cetyl Myristoleate (CMO) In Medical Treatments

#1345
20190008816
2019-01-10

Method for extending lifespan delaying the onset of age-related disease

#1346
20190008805
2019-01-10

BUPROPION AND DEXTROMETHORPHAN FOR TREATING NICOTINE ADDICTION

#1347
20190008802
2019-01-10

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

#1348
20190008801
2019-01-10

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#1349
20190008800
2019-01-10

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#1350
20190008777
2019-01-10

Celecoxib and amlodipine formulation and method of making the same

#1351
20190008763
2019-01-10

COPPER INTRAUTERINE DEVICE

#1352
20190008746
2019-01-10

Oral Hygiene Products and Method of Using the Same

#1353
20190008723
2019-01-10

Container assembly

#1354
20190008188
2019-01-10

Antihistamines Combined with Dietary Supplements for Improved Health

#1355
20190002560
2019-01-03

Anti-CD33 antibodies and methods of use thereof

#1356
20190002534
2019-01-03

Human antibodies against rabies and uses thereof

#1357
20190002512
2019-01-03

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#1358
20190002480
2019-01-03

Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases

#1359
20190002472
2019-01-03

Immunoregulatory agents

#1360
20190002447
2019-01-03

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

#1361
20190002435
2019-01-03

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

#1362
20190002390
2019-01-03

Compositions and methods of use of phorbol esters in the treatment of neoplasms

#1363
20190000936
2019-01-03

PROPHYLACTIC NORMALIZATION OF CUTANEOUS WOUND REPAIR

#1364
20190000934
2019-01-03

SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa

#1365
20190000931
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

#1366
20190000930
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

#1367
20190000920
2019-01-03

Methods of treating lung cancer

#1368
20190000919
2019-01-03

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

#1369
20190000915
2019-01-03

Methods for the regulation of matrix metalloproteinase expression

#1370
20190000909
2019-01-03

INHIBITING OR INACTIVATING THE VIRULENCE OF A LIVE PATHOGEN

#1371
20190000906
2019-01-03

Composition, containing extracts of and as active ingredients, for promoting motor ability and muscles

#1372
20190000880
2019-01-03

IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY

#1373
20190000876
2019-01-03

STABILIZED ANTISEPTIC PREPARATIONS

#1374
20190000865
2019-01-03

MATERIALS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND FOR INDUCTION OF ION SECRETION

#1375
20190000856
2019-01-03

MTH1 inhibitors for treatment of inflammatory and autoimmune conditions

#1376
20190000855
2019-01-03

TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN

#1377
20190000841
2019-01-03

Method of treating a brain tumor

#1378
20190000838
2019-01-03

Synthetic lethality and the treatment of cancer

#1379
20190000835
2019-01-03

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

#1380
20190000833
2019-01-03

ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE

#1381
20190000831
2019-01-03

Compositions and methods for treating drug-tolerant glioblastoma

#1382
20190000826
2019-01-03

ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS

#1383
20190000815
2019-01-03

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#1384
20190000814
2019-01-03

Antifungal compounds

#1385
20190000807
2019-01-03

Organic compounds

#1386
20190000802
2019-01-03

DRUG COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USING THEM

#1387
20190000800
2019-01-03

Composition comprising a diindolylmethane and a retinoid to treat a skin condition

#1388
20190000797
2019-01-03

Tumor therapeutic agent

#1389
20190000786
2019-01-03

Methods of diagnosing and treating infected implants

#1390
20190000782
2019-01-03

COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES AND SIDE-EFFECTS ASSOCIATED WITH COGNITION EFFECTING PHARMACEUTICALS

#1391
20190000780
2019-01-03

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#1392
20190000762
2019-01-03

Emulsion formulations of an NK-1 receptor antagonist and uses thereof

#1393
20180371093
2018-12-27

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

#1394
20180371021
2018-12-27

PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF

#1395
20180370933
2018-12-27

Compounds and compositions for inhibition of FASN

#1396
20180369452
2018-12-27

Combination compositions

#1397
20180369381
2018-12-27

Vitamin D3 and analogs thereof for treating alopecia

#1398
20180369375
2018-12-27

Anti-LAG3 antibodies and antigen-binding fragments

#1399
20180369372
2018-12-27

Compositions and methods of treating sarcoma lung metastasis

#1400
20180369345
2018-12-27

Treatment of diabetic nerve injury comprising administering plasminogen

#1401
20180369339
2018-12-27

Methods and compositions for oral administration of proteins

#1402
20180369331
2018-12-27

Use of FGF19 to increase muscle fiber size

#1403
20180369321
2018-12-27

Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production

#1404
20180369305
2018-12-27

Methods of mitigating the negative effects of endurance exercise

#1405
20180369289
2018-12-27

CELL TRANSPLANTATION DEVICE

#1406
20180369283
2018-12-27

Methods of conditioning patients for T cell therapy

#1407
20180369280
2018-12-27

High affinity T cell receptors and uses thereof

#1408
20180369275
2018-12-27

Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome

#1409
20180369264
2018-12-27

COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS

#1410
20180369263
2018-12-27

Therapeutic method and therapeutic agent for atopic dermatitis in animals

#1411
20180369259
2018-12-27

Combination therapy effective against microorganisms, including drug resistant microorganisms

#1412
20180369249
2018-12-27

Purine compounds possessing anticancer activity

#1413
20180369248
2018-12-27

Layered sustained-release microbeads and methods of making the same

#1414
20180369244
2018-12-27

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment

#1415
20180369241
2018-12-27

TREATMENT OF CANCER WITH DNAPK INHIBITORS

#1416
20180369228
2018-12-27

COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE

#1417
20180369224
2018-12-27

NOVEL PIPERIDINE COMPOUND OR SALT THEREOF

#1418
20180369223
2018-12-27

Compositions and methods for selectively depleting senescent cells

#1419
20180369217
2018-12-27

Therapeutic methods and combinations

#1420
20180369212
2018-12-27

Sphingosine pathway modulating compounds for the treatment of cancers

#1421
20180369207
2018-12-27

Rufinamide for use in the treatment of myotonia

#1422
20180369204
2018-12-27

Pharmaceutical combinations for treating cancer

#1423
20180369203
2018-12-27

METHODS OF TREATING CANCER BY ADMINISTERING A MEK INHIBITOR IN COMBINATION WITH A PROTEASOME INHIBITOR

#1424
20180369201
2018-12-27

DBH inhibitors for treating memory loss

#1425
20180369195
2018-12-27

COMBINATION THERAPY FOR TREATMENT OF MELANOMA

#1426
20180369191
2018-12-27

Blended cannabis compounds and methods of making the same

#1427
20180369180
2018-12-27

DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

#1428
20180369174
2018-12-27

METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL NEUROPATHY

#1429
20180369171
2018-12-27

PPAR-alpha agonist treatment of neuropsychiatric disorders

#1430
20180369169
2018-12-27

Sphingosine pathway modulating compounds for the treatment of cancers

#1431
20180369167
2018-12-27

Methods for treating cancer

#1432
20180369165
2018-12-27

Deacetylnemorone abietane diterpenoids for use in cancer treatment

#1433
20180369158
2018-12-27

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

#1434
20180364216
2018-12-20

Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same

#1435
20180363071
2018-12-20

METHOD FOR DETECTING INFECTIOUS PARVOVIRUS IN PHARMACEUTICAL PREPARATIONS

#1436
20180362958
2018-12-20

Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

#1437
20180362650
2018-12-20

PD-1 SIGNAL INHIBITOR COMBINATION THERAPY

#1438
20180362631
2018-12-20

Pan-ELR+ CXC chemokine antibodies

#1439
20180362619
2018-12-20

VARIANT ANTIBODIES FOR SITE-SPECIFIC CONJUGATION

#1440
20180362536
2018-12-20

Crystalline forms of a Bruton's tyrosine kinase inhibitor

#1441
20180362535
2018-12-20

Crystalline forms of a Bruton's tyrosine kinase inhibitor

#1442
20180362526
2018-12-20

1H-pyrrolo [2,3-b] pyridine derivatives and their use as kinase inhibitors

#1443
20180362500
2018-12-20

VITAMIN D RECEPTOR-COREGULATOR INHIBITORS

#1444
20180360979
2018-12-20

Bioorthogonal compositions

#1445
20180360970
2018-12-20

Biomaterials for delivery of blood extracts and methods of using same

#1446
20180360956
2018-12-20

Method of reducing reactogenicity induced by administration of vaccine or immunogenic composition

#1447
20180360929
2018-12-20

ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG

#1448
20180360928
2018-12-20

High concentration alpha-glucosidase compositions for the treatment of pompe disease

#1449
20180360918
2018-12-20

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid

#1450
20180360906
2018-12-20

METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION

#1451
20180360874
2018-12-20

Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli

#1452
20180360861
2018-12-20

PRODUCT AND METHOD FOR TREATMENT OF BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION

#1453
20180360853
2018-12-20

Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases

#1454
20180360852
2018-12-20

System and method for diagnosis and treatment

#1455
20180360848
2018-12-20

Pharmaceutical compositions containing testosterone and an aromatase inhibitor

#1456
20180360843
2018-12-20

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

#1457
20180360838
2018-12-20

7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy

#1458
20180360836
2018-12-20

Methods and compositions for inhibition of polymerase

#1459
20180360827
2018-12-20

METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS

#1460
20180360826
2018-12-20

Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826

#1461
20180360823
2018-12-20

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#1462
20180360808
2018-12-20

VAP-1 INHIBITORS FOR TREATING PAIN

#1463
20180360807
2018-12-20

METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST

#1464
20180360804
2018-12-20

Tesofensine and beta blocker combination formulations

#1465
20180360797
2018-12-20

Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system

#1466
20180360792
2018-12-20

Method of Treatment of Alopecia with Monoterpenoids

#1467
20180360791
2018-12-20

FATTY ACID MONOGLYCERIDE COMPOSITIONS

#1468
20180360784
2018-12-20

X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF MIGRAINE

#1469
20180360783
2018-12-20

Methods and compositions for treatment of demyelinating diseases

#1470
20180360777
2018-12-20

Therapy for kinase-dependent malignancies

#1471
20180360774
2018-12-20

Curcumin-based compositions and methods of use thereof

#1472
20180360772
2018-12-20

Low-temperature inhalation administration of cannabinoid entities

#1473
20180360759
2018-12-20

Enzyme delivery systems and methods of preparation and use

#1474
20180360094
2018-12-20

Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support

#1475
20180355021
2018-12-13

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

#1476
20180354983
2018-12-13

Cyclic dinucleotides for cytokine induction

#1477
20180354914
2018-12-13

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

#1478
20180353646
2018-12-13

3-DIMENSIONAL CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX

#1479
20180353570
2018-12-13

Methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions

#1480
20180353556
2018-12-13

Method of identifying a biologically-active composition from a biofilm

#1481
20180353546
2018-12-13

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

#1482
20180353544
2018-12-13

Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type

#1483
20180353530
2018-12-13

Combination Therapeutic Agent For The Treatment Of Macular Degeneration

#1484
20180353523
2018-12-13

CONJOINT THERAPIES WITH INHIBITORS OF GLUCOSE PRODUCTION

#1485
20180353510
2018-12-13

Treatment of Biliary Duct Cancer

#1486
20180353498
2018-12-13

Reducing memory loss in mammals suffering from Alzheimer's disease

#1487
20180353497
2018-12-13

Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders

#1488
20180353495
2018-12-13

PHARMACEUTICAL COMBINATIONS COMPRISING A PI3K INHIBITOR FOR THE TREATMENT OF CANCER

#1489
20180353493
2018-12-13

TREATMENT METHOD BY COMBINED USE OF MDM2 INHIBITOR AND BTK INHIBITOR

#1490
20180353488
2018-12-13

Combination therapy for treatment of restenosis

#1491
20180353478
2018-12-13

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#1492
20180353473
2018-12-13

Use of amisulpride as an anti-emetic

#1493
20180353469
2018-12-13

Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility

#1494
20180353466
2018-12-13

PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER

#1495
20180353451
2018-12-13

BROMFENAC BIOAVAILABILITY

#1496
20180353450
2018-12-13

METHODS AND COMPOSITIONS FOR TREATING DEMYELINATING DISEASES USING SOBETIROME OR A SOBETIROME PRODRUG AND A PPAR ACTIVATOR

#1497
20180353449
2018-12-13

Drug combination with antitumor effects

#1498
20180353425
2018-12-13

Methods of treatment of cancer by continuous infusion of coenzyme Q10

#1499
20180346914
2018-12-06

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

#1500
20180346609
2018-12-06

Alkylated cyclodextrin compositions and processes for preparing and using the same